Cell therapy companies
Companies whose enriched business profile is tagged “Cell therapy”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.
- CRISPR THERAPEUTICS AG (CRSP) Health Care — CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and beta thalassemia, plus a pipeline of in vivo and cell therapy programs. ask →
- VOR BIOPHARMA INC (VOR) Health Care — Vor Biopharma is a clinical-stage biopharmaceutical company developing advanced cell therapy and gene therapy solutions for blood disorders and cancers. ask →
- JANUX THERAPEUTICS INC (JANX) Health Care — Janux Therapeutics is a clinical-stage biotech developing next-generation, tumor-activated bispecific immunotherapies to improve the safety and efficacy of cancer and autoimmune treatments. ask →
- CERUS CORP (CERS) Health Care — Cerus develops pathogen-inactivation technologies for blood transfusions and cellular therapy products, with the INTERCEPT Blood System as its lead commercial offering. ask →
- PROKIDNEY CORP CLASS A (PROK) Health Care — ProKidney is pioneering a first-in-class autologous kidney cell therapy to slow kidney function decline in advanced CKD and diabetes patients, currently in Phase 3 trials with FDA RMAT designation. ask →
- ARTIVA BIOTHERAPEUTICS INC (ARTV) Health Care — Artiva Biotherapeutics develops allogeneic natural killer cell immunotherapies for cancer, with its lead candidate AlloNK advancing through clinical trials. ask →
- CABALETTA BIO INC (CABA) Health Care — Cabaletta Bio is a clinical-stage biotechnology firm developing one-time, curative CAR T cell therapies aimed at resetting the immune system for patients with complex autoimmune diseases. ask →
- KYVERNA THERAPEUTICS INC (KYTX) Health Care — Kyverna is a clinical-stage immunology biotech developing novel investigational therapeutics with no approved products and complete dependence on successful clinical trial outcomes. ask →
- LINEAGE CELL THERAPEUTICS INC (LCTX) Health Care — Lineage Cell Therapeutics develops allogeneic cell therapy treatments for serious human diseases through its AlloSCOPE™ manufacturing platform and partnerships with major pharmaceutical companies. ask →
- PROTARA THERAPEUTICS INC (TARA) Health Care — Clinical-stage biopharmaceutical company developing TARA-002, a cell therapy based on an established immunopotentiator, and IV Choline Chloride for oncology, rare diseases, and nutritional support. ask →
- MaxCyte, Inc. (MXCT) Health Care — MaxCyte enables cell therapy development through proprietary electroporation technology that delivers molecules into cells for engineering next-generation cell-based medicines. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest cell therapy companies?
By market capitalization, the largest cell therapy companies in the catalog include CRISPR THERAPEUTICS AG (CRSP), VOR BIOPHARMA INC (VOR), JANUX THERAPEUTICS INC (JANX), CERUS CORP (CERS), PROKIDNEY CORP CLASS A (PROK).
How many cell therapy companies does stocks-llm track?
stocks-llm currently lists 11 cell therapy companies (as of 2026-07-22), each with dated fundamentals from SEC EDGAR and Finnhub. Informational only — not financial advice.
Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.